Status:
UNKNOWN
Topical Adrenaline Versus Warm Saline Solution for Minimizing Intraperitoneal Bleeding During Caesarian Delivery for Placenta Previa / Accreta Spectrum ( PAS)
Lead Sponsor:
Cairo University
Conditions:
Placenta Accreta
Placenta Previa
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Placenta accreta spectrum (PAS), encompassing the terms placenta accreta, increta, and percreta; abnormally invasive placenta; morbidly adherent placenta; and invasive placentation, is a leading cause...
Detailed Description
* Population of study: A total of 84 pregnant patients with placenta previa / Accreta spectrum. * Study location: Obstetrics and Gynecology Kasr Al-Ainy Hospital , Faculty of Medicine , Cairo Universi...
Eligibility Criteria
Inclusion
- Age from 18 to 40 years.
- BMI \< 35.
- Pregnant patients with placenta previa .
- Placenta accrete spectrum.
- Vitally stable .
Exclusion
- Vitally unstable .
- Massive pre- or intra-operative bleeding.
- Medical disorders ( e.g. : hypertension , cardiac …. )
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 25 2023
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06030479
Start Date
February 1 2023
End Date
October 25 2023
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy outpatient clinic
Cairo, Egypt